Technical Analysis for QTNT - Quotient Limited

Grade Last Price % Change Price Change
grade B 9.72 -3.09% -0.31
QTNT closed down 3.09 percent on Friday, February 15, 2019, on 1.85 times normal volume. The bulls were able to push the stock to a new 52-week high. Due to the stock's strong uptrend, it may remain overbought for a while. So, if you're looking for a reason to sell, don't put too much weight on it being overbought.
2 Watchers
View Intraday Alerts Watchlist Portfolio

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong Up Up Up
See historical QTNT trend table...

Date Alert Name Type % Chg
Feb 15 New 52 Week High Strength 0.00%
Feb 15 Multiple of Ten Bearish Other 0.00%
Feb 15 Wide Bands Range Expansion 0.00%
Feb 15 Overbought Stochastic Strength 0.00%
Feb 14 New 52 Week Closing High Bullish -3.09%
Feb 14 New 52 Week High Strength -3.09%
Feb 14 Stochastic Reached Overbought Strength -3.09%
Feb 14 Multiple of Ten Bullish Other -3.09%
Feb 14 Wide Bands Range Expansion -3.09%
Feb 14 Overbought Stochastic Strength -3.09%

Older signals for QTNT ...

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Read My Charts!
Configure default chart indicators
Basic chart:

Profile
Quotient Limited is a commercial-stage transfusion diagnostics company. It is focused on supplying blood-grouping consumables and developing MosaiQ, a fully automated platform for use in donor centers and patient-testing sites. Quotient Limited is headquartered in Edinburgh, Scotland and Newton, Pennsylvania.
Blood Transfusion Medicine Hematology
Is QTNT a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 4 bullish, 0 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Recent News
Date Title
Feb 15 Quotient Limited to Participate in the 8th Annual SVB Leerink Global Healthcare Conference
Feb 1 Quotient Ltd (QTNT) Q3 2019 Earnings Conference Call Transcript
Jan 31 Edited Transcript of QTNT earnings conference call or presentation 31-Jan-19 1:30pm GMT
Jan 31 Quotient Limited (QTNT) CEO Franz Walt on Q3 2019 Results - Earnings Call Transcript
Jan 31 Quotient (QTNT) Reports Q3 Loss, Tops Revenue Estimates
Jan 31 Quotient beats fiscal Q3 consensus
Jan 31 Quotient: Fiscal 3Q Earnings Snapshot
Jan 31 Quotient beats by $0.01, beats on revenue
Jan 31 Quotient Limited Provides an Update on Extended Immunohematology Microarray Performance and on the Commencement of the Initial Serological Disease Screening Field Trial together with Third Quarter Fiscal 2019 Results
Jan 24 Quotient (QTNT) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
See more QTNT news...
Indicators
Indicator Value
52 Week High 10.355
52 Week Low 3.69
Average Volume 419,064
200-Day Moving Average 7.1186
50-Day Moving Average 7.5482
20-Day Moving Average 8.817
10-Day Moving Average 9.503
Average True Range 0.4989
ADX 41.37
+DI 35.8366
-DI 11.1488
Chandelier Exit (Long, 3 ATRs ) 8.8583
Chandelier Exit (Short, 3 ATRs ) 8.6067
Upper Bollinger Band 10.4937
Lower Bollinger Band 7.1403
Percent B (%b) 0.77
BandWidth 38.033345
MACD Line 0.6666
MACD Signal Line 0.6371
MACD Histogram 0.0295
Fundamentals Value
Market Cap 139.74 Million
Num Shares 14.4 Million
EPS -2.88
Price-to-Earnings (P/E) Ratio -3.38
Price-to-Sales 3.14
Price-to-Book 42.86
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 10.79
Resistance 3 (R3) 10.89 10.62 10.61
Resistance 2 (R2) 10.62 10.35 10.57 10.55
Resistance 1 (R1) 10.17 10.18 10.04 10.08 10.49
Pivot Point 9.91 9.91 9.84 9.86 9.91
Support 1 (S1) 9.46 9.63 9.32 9.36 8.95
Support 2 (S2) 9.19 9.46 9.14 8.89
Support 3 (S3) 8.74 9.19 8.83
Support 4 (S4) 8.65